Key Market Indicators
Chilean sales of beta-blocking medicine are projected to reach $40 million by 2026. This is an increase of 2.4% year-on-year, compared to the $35 million seen in 2021. Since 2005, the Chilean market has grown by 4.2% annually. In 2021, Chile ranked 14th in this sector, with Hungary leading the way at $35 million. Italy, Canada and Australia placed 2nd, 3rd and 4th respectively.
